Literature DB >> 20231695

Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected].

Marianna Penzo1, Raffaella Molteni, Tomomi Suda, Sylvia Samaniego, Angela Raucci, David M Habiel, Frederick Miller, Hui-Ping Jiang, Jun Li, Ruggero Pardi, Roberta Palumbo, Eleonora Olivotto, Richard R Kew, Marco E Bianchi, Kenneth B Marcu.   

Abstract

Inhibitor of NF-kappaB kinases beta (IKKbeta) and alpha (IKKalpha) activate distinct NF-kappaB signaling modules. The IKKbeta/canonical NF-kappaB pathway rapidly responds to stress-like conditions, whereas the IKKalpha/noncanonical pathway controls adaptive immunity. Moreover, IKKalpha can attenuate IKKbeta-initiated inflammatory responses. High mobility group box 1 (HMGB1), a chromatin protein, is an extracellular signal of tissue damage-attracting cells in inflammation, tissue regeneration, and scar formation. We show that IKKalpha and IKKbeta are each critically important for HMGB1-elicited chemotaxis of fibroblasts, macrophages, and neutrophils in vitro and neutrophils in vivo. By time-lapse microscopy we dissected different parameters of the HMGB1 migration response and found that IKKalpha and IKKbeta are each essential to polarize cells toward HMGB1 and that each kinase also differentially affects cellular velocity in a time-dependent manner. In addition, HMGB1 modestly induces noncanonical IKKalpha-dependent p52 nuclear translocation and p52/RelB target gene expression. Akin to IKKalpha and IKKbeta, p52 and RelB are also required for HMGB1 chemotaxis, and p52 is essential for cellular orientation toward an HMGB1 gradient. RAGE, a ubiquitously expressed HMGB1 receptor, is required for HMGB1 chemotaxis. Moreover, IKKbeta, but not IKKalpha, is required for HMGB1 to induce RAGE mRNA, suggesting that RAGE is at least one IKKbeta target involved in HMGB1 migration responses, and in accord with these results enforced RAGE expression rescues the HMGB1 migration defect of IKKbeta, but not IKKalpha, null cells. Thus, proinflammatory HMGB1 chemotactic responses mechanistically require the differential collaboration of both IKK-dependent NF-kappaB signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231695      PMCID: PMC2915896          DOI: 10.4049/jimmunol.0903131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

Authors:  Giuseppina Bonizzi; Michael Karin
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

Review 2.  IkappaB kinases: key regulators of the NF-kappaB pathway.

Authors:  Yumi Yamamoto; Richard B Gaynor
Journal:  Trends Biochem Sci       Date:  2004-02       Impact factor: 13.807

Review 3.  HMGB1 loves company.

Authors:  Marco E Bianchi
Journal:  J Leukoc Biol       Date:  2009-05-04       Impact factor: 4.962

4.  The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

Authors:  Hulda Sigridur Hreggvidsdottir; Therese Ostberg; Heidi Wähämaa; Hanna Schierbeck; Ann-Charlotte Aveberger; Lena Klevenvall; Karin Palmblad; Lars Ottosson; Ulf Andersson; Helena Erlandsson Harris
Journal:  J Leukoc Biol       Date:  2009-06-29       Impact factor: 4.962

5.  IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis.

Authors:  Alok K Sil; Shin Maeda; Yuji Sano; Dennis R Roop; Michael Karin
Journal:  Nature       Date:  2004-04-08       Impact factor: 49.962

6.  Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family.

Authors:  T J Fleming; M L Fleming; T R Malek
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

7.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.

Authors:  Giuseppina Bonizzi; Magali Bebien; Dennis C Otero; Kirsten E Johnson-Vroom; Yixue Cao; Don Vu; Anil G Jegga; Bruce J Aronow; Gourisankar Ghosh; Robert C Rickert; Michael Karin
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

8.  Mouse bone marrow contains large numbers of functionally competent neutrophils.

Authors:  Rachel Boxio; Carine Bossenmeyer-Pourié; Natacha Steinckwich; Christian Dournon; Oliver Nüsse
Journal:  J Leukoc Biol       Date:  2003-12-23       Impact factor: 4.962

9.  Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells.

Authors:  Lara Campana; Lidia Bosurgi; Marco E Bianchi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  J Leukoc Biol       Date:  2009-05-04       Impact factor: 4.962

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  49 in total

1.  HMGB1-Neutralizing IgM Antibody Is a Normal Component of Blood Plasma.

Authors:  Yajun Geng; Gnanasekar Munirathinam; Sunil Palani; Joseph E Ross; Bin Wang; Aoshuang Chen; Guoxing Zheng
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

2.  The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1.

Authors:  Richard R Kew; Marianna Penzo; David M Habiel; Kenneth B Marcu
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

Review 3.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

4.  High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

Authors:  Sharon McClellan; Xiaoyu Jiang; Ronald Barrett; Linda D Hazlett
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

5.  The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis.

Authors:  Sami Banerjee; Arnaud Friggeri; Gang Liu; Edward Abraham
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

6.  Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells.

Authors:  Jessica E Thaxton; Bei Liu; Pan Zheng; Yang Liu; Zihai Li
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

7.  The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1.

Authors:  Mao Wang; Samir Gorasiya; Daniel J Antoine; Ravikumar A Sitapara; Wenjun Wu; Lokesh Sharma; Huan Yang; Charles R Ashby; Divya Vasudevan; Michelle Zur; Douglas D Thomas; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

Review 8.  The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Authors:  Daniel J Weber; Yohance M Allette; David S Wilkes; Fletcher A White
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

9.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

10.  Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling.

Authors:  Richard R Kew; Kenneth B Marcu; Marianna Penzo; David M Habiel; Mahalakshmi Ramadass
Journal:  Biochim Biophys Acta       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.